Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk

NCT04128163 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: QL1206
DRUG: Placebos

Sponsor

Qilu Pharmaceutical Co., Ltd.